Kaitlyn Elizabeth Johnson

Kaitlyn Elizabeth Johnson

Auto-generated profile, based on publicly available information

Kaitlyn Elizabeth Johnson

Department of Infectious Disease Epidemiology & Dynamics, The London School of Hygiene & Tropical Medicine, London, England

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2019 in PLOS Biology
Verified
Journal Article
Open access
PDF file
KJKaitlyn E. Johnson
Kaitlyn E. Johnson
GHGrant Howard
Grant Howard
WMWilliam Mo
William Mo
MSMichael K. Strasser
Michael K. Strasser
ELErnesto Augusto Bueno da Fonseca Lima
Ernesto Augusto Bueno da Fonseca Lima
ABAmy Brock
Amy Brock
Most models of cancer cell population expansion assume exponential growth kinetics at low cell densities, with deviations to account for observed slowing of growth rate only at higher densities due to limited resources such as space and nutrients. However, recent preclinical and clinical observations of tumor initiation or recurrence indicate the presence of tumor growth kinetics in which growth rates scale positively with cell numbers. These observations are analogous to the cooperative behavior of species in an ecosystem described by the ecological principle of the Allee effect. In preclinical and clinical models, however, tumor growth data are limited by the lower limit of detection (i.e., a measurable lesion) and confounding variables, such as tumor microenvironment, and immune responses may cause and mask deviations from exponential growth models. In this work, we present alternative growth models to investigate the presence of an Allee effect in cancer cells seeded at low cell densities in a controlled in vitro setting. We propose a stochastic modeling framework to disentangle expected deviations due to small population size stochastic effects from cooperative growth and use the moment approach for stochastic parameter estimation to calibrate the observed growth trajectories. We validate the framework on simulated data and apply this approach to longitudinal cell proliferation data of BT-474 luminal B breast cancer cells. We find that cell population growth kinetics are best described by a model structure that considers the Allee effect, in that the birth rate of tumor cells increases with cell number in the regime of small population size. This indicates a potentially critical role of cooperative behavior among tumor cells at low cell densities with relevance to early stage growth patterns of emerging and relapsed tumors.

1 December 2020 in iScience
Verified
Journal Article
Open access
AKAnum Kazerouni
Anum Kazerouni
MGManasa Gadde
Manasa Gadde
AGAndrea Gardner
Andrea Gardner
DIDavid A. Hormuth, II
David A. Hormuth, II
AJAngela M. Jarrett
Angela M. Jarrett
TYThomas Yankeelov
Thomas Yankeelov
We provide an overview on the use of biological assays to calibrate and initialize mechanism-based models of cancer phenomena. Although artificial intelligence methods currently dominate the landscape in computational oncology, mathematical models that seek to explicitly incorporate biological mechanisms into their formalism are of increasing interest. These models can guide experimental design and provide insights into the underlying mechanisms of cancer progression. Historically, these models have included a myriad of parameters that have been difficult to quantify in biologically relevant systems, limiting their practical insights. Recently, however, there has been much interest calibrating biologically based models with the quantitative measurements available from (for example) RNA sequencing, time-resolved microscopy, and in vivo imaging. In this contribution, we summarize how a variety of experimental methods quantify tumor characteristics from the molecular to tissue scales and describe how such data can be directly integrated with mechanism-based models to improve predictions of tumor growth and treatment response.

13 August 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GHGrant R. Howard
Grant R. Howard
KJKaitlyn E. Johnson
Kaitlyn E. Johnson
AAAreli Rodriguez Ayala
Areli Rodriguez Ayala
TYThomas Yankeelov
Thomas Yankeelov
ABAmy Brock
Amy Brock
The development of resistance to chemotherapy is a major cause of treatment failure in breast cancer. While mathematical models describing the dynamics of resistant cancer cell subpopulations have been proposed, experimental validation has been difficult due to the complex nature of resistance that limits the ability of a single phenotypic marker to sufficiently identify the drug resistant subpopulations. We address this problem with a coupled experimental/modeling approach to reveal the composition of drug resistant subpopulations changing in time following drug exposure. We calibrate time-resolved drug sensitivity assays to three mathematical models to interrogate the models’ ability to capture drug response dynamics. The Akaike information criterion was employed to evaluate the three models, and it identified a multi-state model incorporating the role of population heterogeneity and cellular plasticity as the optimal model. To validate the model’s ability to identify subpopulation composition, we mixed different proportions of wild-type MCF-7 and MCF-7/ADR resistant cells and evaluated the corresponding model output. Our blinded two-state model was able to estimate the proportions of cell types with an R-squared value of 0.857. To the best of our knowledge, this is the first work to combine experimental time-resolved drug sensitivity data with a mathematical model of resistance development.

10 November 2020 in Physical Biology
Verified
Journal Article
Closed access
KJKaitlyn E Johnson
Kaitlyn E Johnson
GHGrant R Howard
Grant R Howard
DMDaylin Morgan
Daylin Morgan
EBEric A Brenner
Eric A Brenner
AGAndrea L Gardner
Andrea L Gardner
ABAmy Brock
Amy Brock
A significant challenge in the field of biomedicine is the development of methods to integrate the multitude of dispersed data sets into comprehensive frameworks to be used to generate optimal clinical decisions. Recent technological advances in single cell analysis allow for high-dimensional molecular characterization of cells and populations, but to date, few mathematical models have attempted to integrate measurements from the single cell scale with other types of longitudinal data. Here, we present a framework that actionizes static outputs from a machine learning model and leverages these as measurements of state variables in a dynamic model of treatment response. We apply this framework to breast cancer cells to integrate single cell transcriptomic data with longitudinal bulk cell population (bulk time course) data. We demonstrate that the explicit inclusion of the phenotypic composition estimate, derived from single cell RNA-sequencing data (scRNA-seq), improves accuracy in the prediction of new treatments with a concordance correlation coefficient (CCC) of 0.92 compared to a prediction accuracy of CCC = 0.64 when fitting on longitudinal bulk cell population data alone. To our knowledge, this is the first work that explicitly integrates single cell clonally-resolved transcriptome datasets with bulk time-course data to jointly calibrate a mathematical model of drug resistance dynamics. We anticipate this approach to be a first step that demonstrates the feasibility of incorporating multiple data types into mathematical models to develop optimized treatment regimens from data.

1 March 2019 in European Journal of Cancer
Verified
Journal Article
Closed access
KJKaitlyn Johnson
Kaitlyn Johnson
AGAxel Gomez
Axel Gomez
JBJackson Burton
Jackson Burton
DWDouglas White
Douglas White
ACArijit Chakravarty
Arijit Chakravarty
DBDean Bottino
Dean Bottino

25 March 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KJKaitlyn E. Johnson
Kaitlyn E. Johnson
MSMadison Stoddard
Madison Stoddard
RNRyan P. Nolan
Ryan P. Nolan
DWDouglas E. White
Douglas E. White
NHNatasha S. Hochberg
Natasha S. Hochberg
ACArijit Chakravarty
Arijit Chakravarty
As the world grapples with the ongoing COVID-19 pandemic, a particularly thorny set of questions surrounds the reopening of primary and secondary (K-12) schools. The benefits of in-person learning are numerous, in terms of education quality, mental health, emotional well-being, equity and access to food and shelter. Early reports suggested that children might have reduced susceptibility to COVID-19, and children have been shown to experience fewer complications than older adults. Over the past few months, our understanding of COVID-19 has been further shaped by emerging data, and it is now understood that children are as susceptible to infection as adults and have a similar viral load during infection, even if asymptomatic. Based on this updated understanding of the disease, we have used epidemiological modeling to explore the feasibility and consequences of school reopening in the face of differing rates of COVID-19 prevalence and transmission. We focused our analysis on the United States, but the results are applicable to other countries as well. We demonstrate the potential for a large discrepancy between detected cases and true infections in schools due to the combination of high asymptomatic rates in children coupled with delays in seeking testing and receiving results from diagnostic tests. Our findings indicate that, regardless of the initial prevalence of the disease, and in the absence of robust surveillance testing and contact-tracing, most schools in the United States can expect to remain open for 20–60 days without the emergence of sizeable disease clusters. At this point, even if schools choose to close after outbreaks occur, COVID-19 cases will be seeded from these school clusters and amplified into the community. Thus, our findings suggest that the debate between the risks to student safety and benefits of in-person learning frames a false dual choice. Reopening schools without surveillance testing and contact tracing measures in place will lead to spread within the schools and within the communities that eventually forces a return to remote learning and leaves a trail of infection in its wake.